Disease/Infection News

RSS

Fewer deer, less Lyme disease

Since white-tailed deer serve as the primary host for the adult blacklegged tick (Ixodes scapularis) - the vector for Lyme disease - scientists have wondered whether reducing the number of deer in a given area would also mean fewer cases of Lyme disease. Now, after a 13-year study was conducted, researchers in Connecticut have found that reduced deer populations can indeed lead to a reduction in Lyme disease cases.

2 Jul 2014

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival.

2 Jul 2014

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Gateway Apothecary in St. Louis, Mo., has received a Peter M. Fox Excellence in HIV Credentialing Award for 2014. Gateway was the only pharmacy to be recognized among the 17 nationwide award recipients, which consist primarily of physicians and/or medical practices.

1 Jul 2014

Research shows foodborne pathogen can cause disease in some breeds of poultry

Contrary to popular belief, the foodborne pathogen Campylobacter jejuni is not a harmless commensal in chickens but can cause disease in some breeds of poultry according to research published in mBio-, the online open-access journal of the American Society for Microbiology.

1 Jul 2014

Heavy drinkers at greater risk of developing pneumonia and ARDS

Heavy drinking damages the body in many ways. In addition to liver failure, alcoholics are at a much greater risk of developing pneumonia and life threatening acute respiratory distress syndrome (ARDS), for which there is no treatment.

1 Jul 2014

HIV-positive people with early-stage cancer less likely to get cancer treatment

HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.

1 Jul 2014

Malaria parasites alter chemical odor signal of hosts to attract mosquitos

Malaria parasites alter the chemical odor signal of their hosts to attract mosquitos and better spread their offspring, according to researchers, who believe this scent change could be used as a diagnostic tool.

1 Jul 2014

Researchers find unique cell type that can protect against uveitis

Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss.

1 Jul 2014

Study investigates HPV prevalence and screening methods in developing countries

Health screens for cancer-causing infections like HPV can be challenging in developing countries, where residing in rural areas can result in limited access to health services.

1 Jul 2014

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Wheaton Franciscan Healthcare-Iowa is the latest to deploy TRU-D SmartUVC, a 5-foot-5 germ-killing ultraviolet robot equipped with the only infection prevention data collection and reporting software on the market. TRU-D is now in use at Covenant Medical Center in Waterloo and Sartori Medical Center in Cedar Falls, Iowa.

30 Jun 2014

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)

30 Jun 2014

Sedia Biosciences to present results of HIV incidence assay at International AIDS Conference

Sedia Biosciences Corporation of Portland, Oregon will be presenting its first public results of a new rapid point-of-care HIV incidence assay at the upcoming 20th International AIDS Conference in Melbourne, Australia, July 21-25, 2014.

30 Jun 2014

American Academy of Ophthalmology does not recommend marijuana for glaucoma treatment

The American Academy of Ophthalmology – the world's largest association of eye physicians and surgeons – is reminding the public that it does not recommend marijuana or other cannabis products for the treatment of glaucoma.

28 Jun 2014

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.

28 Jun 2014

Host-directed therapy: A new type of TB treatment

In a new study published in Nature, scientists describe a new type of tuberculosis (TB) treatment that involves manipulating the body's response to TB bacteria rather than targeting the bacteria themselves, a concept called host-directed therapy.

28 Jun 2014

New estimates highlight the importance of developing norovirus vaccines

Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors.

28 Jun 2014

Lassa virus uses two-step process to invade cells, shows study

Scientists have discovered that the Lassa virus, which is endemic to West Africa, uses an unexpected two-step process to enter cells.

28 Jun 2014

Xenex testifies before U.S. House of Representatives on effectiveness of UV disinfection system in reducing HAI rates

Xenex Disinfection Services, the world leader in UV room disinfection systems, testified yesterday before the U.S. House of Representatives Committee on Science, Space, and Technology; Subcommittee on Research and Technology; and Subcommittee on Oversight.

28 Jun 2014

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.

27 Jun 2014

Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

27 Jun 2014

Disease/Infection News

Fewer deer, less Lyme disease

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Research shows foodborne pathogen can cause disease in some breeds of poultry

Heavy drinkers at greater risk of developing pneumonia and ARDS

HIV-positive people with early-stage cancer less likely to get cancer treatment

Malaria parasites alter chemical odor signal of hosts to attract mosquitos

Researchers find unique cell type that can protect against uveitis

Study investigates HPV prevalence and screening methods in developing countries

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Sedia Biosciences to present results of HIV incidence assay at International AIDS Conference

American Academy of Ophthalmology does not recommend marijuana for glaucoma treatment

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

Host-directed therapy: A new type of TB treatment

New estimates highlight the importance of developing norovirus vaccines

Lassa virus uses two-step process to invade cells, shows study

Xenex testifies before U.S. House of Representatives on effectiveness of UV disinfection system in reducing HAI rates

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News